What’s common is the vision and determination they have to get to the end game. They have a tendency to get short with people who want to do things the old way and aren’t looking at ways to move bigger, better, and faster. My believe is some of the old guard who were at Cytodyn frustrated him and didn’t see the vision he did. Because of that , they weren’t well liked by many and he doesn’t tolerate people not being on board.i I think you have to look at biotech in two sections : big Pharma and small pharma . I was in big Pharma for 16 years. The CEOs play it safe. They have lots of revenue, can afford buying the relationships in Washington DC and life for a big Pharma CEO is fairly easy. Their pipelines in many cases aren’t great and use their cash to buy innovative biotech companies who are small. Small Pharma, especially on the OTC have to get the attention of decision makers without having a lot of cash or resources. NP is scrappy and you need to be in an 18 person biotech where shorts are trying to crush you and you are working through a maze to get the attention you need to get your drug approved. Is NP flawed, yes, but his profile fits an underdog trying to make his company successful. Time will tell if his a
Pros have works but I wouldn’t want a big Pharma CEO in his seat. They would not be affective without the resources they are used to having